Home / Conditions / Type 1 Diabetes (page 8)

Type 1 Diabetes

Type 1 Diabetes Treatment and Research: Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells. Once called juvenile diabetes, Type 1 is diagnosed most often in children, but can be expressed in adults as well. Incidence is highest among non-hispanic whites, according to the NDEP. Adults with Type 1 make up 5% of all diagnosed diabetes patients.New tools, techniques, treatments, drugs and devices can help you improve outcomes for your patients with Type 1.

Catching Type 1 Earlier: How Autoantibody Screening Is Changing the Playbook

Conceptual image showing type 1 diabetes autoantibody screening with glucose monitor, test tube, pancreas model, and antibody vials labeled GADA, IA-2A, and ZnT8A.

Type 1 diabetes doesn’t have to be a surprise. Thanks to type 1 diabetes autoantibody screening, clinicians can now identify individuals at high risk before symptoms even appear. This early detection opens doors for proactive monitoring, patient education, and potentially delaying or preventing full-blown disease. But who should be screened? …

Read More »

Preventing DKA and HHS in Outpatient Settings: 2025 Updates Every Clinician Should Apply

Doctor discussing DKA outpatient prevention with a patient; ketone meter, insulin, glucose monitor, and a sick-day plan shown in foreground

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are still two of the most dangerous acute complications facing people with diabetes. However, a large portion of these cases can be prevented outside of the hospital. In 2025, the American Diabetes Association (ADA) released expanded guidance focused on DKA outpatient prevention, …

Read More »

How to Vet Diabetes Devices: A Clinic Checklist for Safe Tech Adoption

A clinic-first diabetes device evaluation checklist to safely assess CGMs, pumps, and health apps for compatibility, security, and patient outcomes.

As diabetes technology evolves at lightning speed, clinics are under increasing pressure to evaluate a growing range of tools—from continuous glucose monitors (CGMs) and insulin pumps to smartphone apps and cloud platforms. But how can healthcare providers make safe, informed decisions about which tools to recommend? A clear, structured diabetes …

Read More »

Safe Use of Diabetes Technology: Reducing Device-Related Risks Without Losing the Benefits

A collection of diabetes technology devices including a CGM, insulin pump, glucose meter, and insulin pen, illustrating safe use strategies.

Diabetes technology safety has become a critical focus as continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems transform diabetes care. These tools improve glycemic outcomes, enhance quality of life, and support proactive management. However, with increased device complexity comes a unique set of risks clinicians must recognize …

Read More »

Addressing Diabetes Distress and Burnout in Routine Visits: A Practical Toolkit for Clinicians

Compassionate doctor supporting a distressed older male diabetes patient during a clinical consultation, with insulin and glucose monitor visible on desk

Diabetes distress and burnout are common but often overlooked challenges affecting people with diabetes. These emotional burdens can negatively influence self‑management, medication adherence, and glycemic control. In routine clinical visits, especially those limited to 15 minutes, clinicians may struggle to address emotional and psychological concerns alongside medical management. However, integrating …

Read More »

Digital Health Fatigue in Diabetes: When Technology Helps and When It Hurts

Stressed middle-aged man with a continuous glucose monitor looking at his phone, surrounded by digital health icons representing alerts and data.

In the era of smartphones, continuous glucose monitoring (CGM), remote portals, and health apps, digital tools offer powerful ways to support people living with diabetes. However, too much technology can overwhelm patients, leading to digital health fatigue in diabetes—a state where users disengage from tools that were meant to help …

Read More »

From A1C to TIR – Rethinking Glycemic Targets for Better Long‑Term Outcomes

A glucose meter reading 117 mg/dL placed over lab results showing Hemoglobin A1c and a Time in Range (TIR) chart with green, yellow, and red bars.

For decades, clinicians have relied on A1C as the primary benchmark for diabetes control. Yet many patients and providers now wonder: does a single quarterly number truly reflect daily glucose fluctuations and risks? As continuous glucose monitoring (CGM) becomes more accessible, the metric known as Time in Range (TIR) has …

Read More »